GERMANTOWN, Md., Sept. 12, 2018 /PRNewswire/ -- Intrexon
Corporation (NYSE: XON), a leader in the engineering and
industrialization of biology to improve the quality of life and
health of the planet, today announced that it is transferring its
stock exchange listing from the New York Stock Exchange (NYSE) to
the Nasdaq Global Select Market (Nasdaq). Intrexon will
retain the "XON" ticker with trading on the Nasdaq exchange
expected to begin on September 25,
2018.
"Following a careful review, we have concluded that our
shareholders will be served better by our listing on Nasdaq, with
its superior technology, trading liquidity, visibility and
opportunities for investor outreach," said Randal J. Kirk, Chairman and Chief Executive
Officer of Intrexon. "We look forward to our partnership with
Nasdaq."
"Intrexon has been driving innovation in the biotechnology
industry with its development and engineering in synthetic
biology," said Nelson Griggs, President of Nasdaq Stock
Exchange. "As home to the leading biotechnology companies, we are
excited to be their exchange partner as the company strives to help
address some of the world's most pressing
challenges."
About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial
Revolution with Better DNA™ to create biologically-based products
that improve the quality of life and the health of the
planet. Intrexon's integrated technology suite provides its
partners across diverse markets with industrial-scale design and
development of complex biological systems delivering unprecedented
control, quality, function, and performance of living cells.
We call our synthetic biology approach Better DNA®, and
we invite you to discover more at www.dna.com or follow us on
Twitter at @Intrexon, on Facebook, and LinkedIn.
Trademarks
Intrexon, Powering the Bioindustrial Revolution with Better DNA,
and Better DNA are trademarks of Intrexon and/or its affiliates.
Other names may be trademarks of their respective owners.
Safe Harbor Statement
Some of the statements made in
this press release are forward-looking statements. These
forward-looking statements are based upon our current expectations
and projections about future events and generally relate to our
plans, objectives and expectations for the development of our
business. Although management believes that the plans and
objectives reflected in or suggested by these forward-looking
statements are reasonable, all forward-looking statements involve
risks and uncertainties and actual future results may be materially
different from the plans, objectives and expectations expressed in
this press release.
For more information regarding Intrexon Corporation,
contact:
Investor
Contact:
Steven
Harasym
Vice President,
Investor Relations
Tel: +1 (214)
721-0607
investors@dna.com
|
Corporate
Contact:
Marie Rossi,
PhD
Vice President,
Communications
Tel: +1 (301)
556-9850
publicrelations@dna.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/intrexon-announces-transfer-of-stock-listing-to-nasdaq-300710809.html
SOURCE Intrexon Corporation